The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
The cell-cycle checkpoint kinase Chk1 is required for mammalian homologous recombination repair
Abstract
The essential checkpoint kinase Chk1 is required for cell-cycle delays after DNA damage or blocked DNA replication. However, it is unclear whether Chk1 is involved in the repair of damaged DNA. Here we establish that Chk1 is a key regulator of genome maintenance by the homologous recombination repair (HRR) system. Abrogation of Chk1 function with small interfering RNA or chemical antagonists inhibits HRR, leading to persistent unrepaired DNA double-strand breaks (DSBs) and cell death after replication inhibition with hydroxyurea or DNA-damage caused by camptothecin. After hydroxyurea treatment, the essential recombination repair protein RAD51 is recruited to DNA repair foci performing a vital role in correct HRR. We demonstrate that Chk1 interacts with RAD51, and that RAD51 is phosphorylated on Thr 309 in a Chk1-dependent manner. Consistent with a functional interplay between Chk1 and RAD51, Chk1-depleted cells failed to form RAD51 nuclear foci after exposure to hydroxyurea, and cells expressing a phosphorylation-deficient mutant RAD51(T309A) were hypersensitive to hydroxyurea. These results highlight a crucial role for the Chk1 signalling pathway in protecting cells against lethal DNA lesions through regulation of HRR.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Both Chk1 and Chk2 regulate the functional associations between BRCA1, BRCA2, and Rad51 proteins in response to DNA damage, and thus promote HR-mediated repair of stalled replication forks [27, 28].”
From NER initiation factors, DDB2 and XPC, regulate UV radiation response by recruiting ATR and ATM kinases to DNA damage sites (2013) · cites this paper as [27]
In the citing paper
“Moreover, both the ATR-Chk1 and ATM-Chk2 pathways regulate HR-mediated repair of collapsed replication forks [27, 28].”
From NER initiation factors, DDB2 and XPC, regulate UV radiation response by recruiting ATR and ATM kinases to DNA damage sites (2013) · cites this paper as [27]
In the citing paper
“activated Chk1 phosphorylates its own substrates such as protein Rad51, which is involved in the DSB repair by HR [193–195]”
From Functional interplay between ATM/ATR-mediated DNA damage response and DNA repair pathways in oxidative stress (2014) · cites this paper as [195]
Citations
Cites
Cell cycle checkpoint signaling through the ATM and ATR kinases
Abraham, R. T. (2001) · Genes & Development · doi:10.1101/gad.914401 · Cited by 1,966
Liu, Q., Guntuku, S., Cui, X.-S., Matsuoka, S., Cortez, D., Tamai, K., Luo, G., Carattini-Rivera, S., DeMayo, F., Bradley, A., et al. (2000) · Genes & Development · doi:10.1101/gad.14.12.1448 · Cited by 1,625
Chk1 and Chk2 kinases in checkpoint control and cancer
Bartek, J., & Lukas, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00110-7 · Cited by 1,513
Sensing and repairing DNA double-strand breaks
Jackson, S. P. (2002) · Carcinogenesis · doi:10.1093/carcin/23.5.687 · Cited by 1,149
ATR-Mediated Checkpoint Pathways Regulate Phosphorylation and Activation of Human Chk1
Zhao, H., & Piwnica-Worms, H. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.13.4129-4139.2001 · Cited by 1,091
(1999) · PubMed · Cited by 1,030
Molecular views of recombination proteins and their control
West, S. C. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1127 · Cited by 977
ATR disruption leads to chromosomal fragmentation and early embryonic lethality
Brown, E. J., & Baltimore, D. (2000) · Genes & Development · doi:10.1101/gad.14.4.397 · Cited by 951
Rad51‐deficient vertebrate cells accumulate chromosomal breaks prior to cell death
Sonoda, E., Sasaki, M., Buerstedde, J., Bezzubova, O., Shinohara, A., Ogawa, H., Takata, M., Yamaguchi-Iwai, Y., & Takeda, S. (1998) · EMBO Journal · doi:10.1093/emboj/17.2.598 · Cited by 860
Targeted disruption of the Rad51 gene leads to lethality in embryonic mice.
Tsuzuki, T., Fujii, Y., Sakumi, K., Tominaga, Y., Nakao, K., Sekiguchi, M., Matsushiro, A., Yoshimura, Y., & MoritaT (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.13.6236 · Cited by 792
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–500 of 662
Chk1 promotes non-homologous end joining in G1 through direct phosphorylation of ASF1A
Lee, K. Y., & Dutta, A. (2021) · Cell Reports · doi:10.1016/j.celrep.2020.108680 · Cited by 17
Chen, L., Hou, J., Zeng, X., Guo, Q., Deng, M., Kloeber, J. A., Tu, X., Zhao, F., Wu, Z., Huang, J., et al. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.341 · Cited by 17
Johansson, F., Lagerqvist, A., Filippi, S., Palitti, F., Erixon, K., Helleday, T., & Jenssen, D. (2006) · DNA repair · doi:10.1016/j.dnarep.2006.07.005 · Cited by 17
Self-citationATR Suppresses Endogenous DNA Damage and Allows Completion of Homologous Recombination Repair
Brown, A., Sager, B. W., Gorthi, A., Tonapi, S. S., Brown, E. J., & Bishop, A. J. R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091222 · Cited by 17
Activation of CHK1 in Supporting Cells Indirectly Promotes Hair Cell Survival
Jadali, A., Ying, Y. M., & Kwan, K. Y. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00137 · Cited by 17
Replicating Damaged DNA in EukaryotesPreprint
Chatterjee, N., & Siede, W. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a019836 · Cited by 17
Lee, S., Kim, J., Jeong, E., & Myung, K. (2025) · DNA repair · doi:10.1016/j.dnarep.2025.103887 · Cited by 16
Watari, A., Hasegawa, M., Yagi, K., & Kondoh, M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0145631 · Cited by 16
DNA damage response is hijacked by human papillomaviruses to complete their life cycle
Hong, S.-Y. (2017) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1600306 · Cited by 17
Novel biological strategies to enhance the radiation therapeutic ratio
Kim, J. H., Jenrow, K. A., & Brown, S. L. (2018) · Radiation Oncology Journal · doi:10.3857/roj.2018.00332 · Cited by 16
Ji, Y., Wang, Q., Zhao, Q., Zhao, S., Li, L., Sun, G., & Ye, L. (2019) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-019-10148-y · Cited by 16
McIntosh, M. T., Koganti, S. R. K., Boatwright, J. L., Li, X., Spadaro, S., Brantly, A. C., Ayers, J. B., Perez, R. D., Burton, E. M., Burgula, S., et al. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008849 · Cited by 16
ATR Inhibitors in Platinum-Resistant Ovarian Cancer
Li, S., Wang, T., Fei, X., & Zhang, M. (2022) · Cancers · doi:10.3390/cancers14235902 · Cited by 16
Human RECQL5 overcomes thymidine-induced replication stress
Blundred, R., Myers, K. N., Helleday, T., Goldman, A. S. H., & Bryant, H. E. (2010) · DNA repair · doi:10.1016/j.dnarep.2010.06.009 · Cited by 16
Self-citationMenin stimulates homology‐directed DNA repair
Gallo, A., Agnese, S., Esposito, I., Galgani, M., & Avvedimento, V. E. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.10.032 · Cited by 16
Stellas, D., Souliotis, V. L., Bekyrou, M., Smirlis, D., Kirsch‐Volders, M., Degrassi, F., Cundari, E., & Kyrtopoulos, S. Α. (2014) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2014.07.004 · Cited by 16
Dissecting cellular responses to irradiation via targeted disruptions of the ATM-CHK1-PP2A circuit
Palii, S. S., Cui, Y., Innes, C. L., & Paules, R. S. (2013) · Cell Cycle · doi:10.4161/cc.24127 · Cited by 16
Fasullo, M., Dong, Z., Sun, M., & Zeng, L. (2005) · DNA repair · doi:10.1016/j.dnarep.2005.06.006 · Cited by 16
Chking And executing cell division to prevent genomic instability
Peddibhotla, S., & Rosen, J. M. (2009) · Cell Cycle · doi:10.4161/cc.8.15.9169 · Cited by 16
Gomha, S. M., Abdulla, M. M., & Abou‐Seri, S. M. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.01.019 · Cited by 15
RetractedLoss of TDP-43 function contributes to genomic instability in amyotrophic lateral sclerosis
Fang, M., Deibler, S. K., Nana, A. L., Vatsavayai, S. C., Banday, S., Zhou, Y., Almeida, S., Weiss, A., Brown, R. H., Seeley, W. W., et al. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1251228 · Cited by 17
Xu, W., Huang, M., Guo, J., Zhang, H., Wang, D., Liu, T., Liu, H., Chen, S., Gao, P., & Mu, K. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.41627 · Cited by 15
Soni, A., Mladenov, E., & Iliakis, G. E. (2021) · DNA repair · doi:10.1016/j.dnarep.2021.103076 · Cited by 16
Determinants of Homologous Recombination Deficiency in Pancreatic Cancer
Wattenberg, M. M., & Reiss, K. A. (2021) · Cancers · doi:10.3390/cancers13184716 · Cited by 15
de Andrade-Lima, L. C., Andrade, L. N. D. S., & Menck, C. F. M. (2014) · Journal of Cell Science · doi:10.1242/jcs.161596 · Cited by 15
Translation of Targeted Radiation Sensitizers into Clinical Trials
Reichert, Z. R., Wahl, D. R., & Morgan, M. A. (2016) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2016.06.001 · Cited by 15
Melia, E., & Parsons, J. L. (2024) · Cancers · doi:10.3390/cancers16173016 · Cited by 14
Post-translational modification of factors involved in homologous recombination
Argunhan, B., Iwasaki, H., & Tsubouchi, H. (2021) · DNA repair · doi:10.1016/j.dnarep.2021.103114 · Cited by 15
Chk1 inhibition-induced BRCAness synergizes with olaparib in p53-deficient cancer cells
Zhao, Y., Zhou, K., Xia, X., Guo, Y., & Li, T. (2022) · Cell Cycle · doi:10.1080/15384101.2022.2111769 · Cited by 14
Cybulski, C., Zamani, N., Kluźniak, W., Milano, L., Wokołorczyk, D., Stempa, K., Rudnicka, H., Zhang, S., Zadeh, M., Huzarski, T., et al. (2023) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2023.03.002 · Cited by 15
Rocca, C. J., Soares, D. G., Bouzid, H., Henriques, J. A. P., Larsen, A. K., & Escargueil, A. E. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1042632 · Cited by 14
Lee, H., Alpi, A. F., Park, M. S., Rose, A. M., & Koo, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060071 · Cited by 14
Yong, K. J., Milenic, D. E., Baidoo, K. E., & Brechbiel, M. W. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159904 · Cited by 14
Iwata, T., Uchino, T., Koyama, A., Johmura, Y., Koyama, K., Saito, T., Ishiguro, S., Arikawa, T., Komatsu, S., Miyachi, M., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178221 · Cited by 14
Differential response of normal and malignant urothelial cells to CHK1 and ATM inhibitors
Wang, W. T., Catto, J. W. F., & Meuth, M. (2014) · Oncogene · doi:10.1038/onc.2014.221 · Cited by 14
Potential Benefits of Combining Proton or Carbon Ion Therapy with DNA Damage Repair Inhibitors
Rødland, G. E., Temelie, M., Mariampillai, A. E., Hauge, S., Gilbert, A., Chevalier, F., Savu, D., & Syljuåsen, R. G. (2024) · Cells · doi:10.3390/cells13121058 · Cited by 14
Self-citationDong, M., Ouyang, Y., Gao, S.-C., Ma, X., Hou, Y., Schatten, H., Wang, Z., & Sun, Q. (2022) · Development · doi:10.1242/dev.200351 · Cited by 13
Fujimori, H., Sato, A., Kikuhara, S., Wang, J., Hirai, T., Sasaki, Y., Murakami, Y., Okayasu, R., & Masutani, M. (2015) · Scientific Reports · doi:10.1038/srep18231 · Cited by 13
Alligand, B., Breton, M. L., Marquis, D., Vallette, F. M., & Fleury, F. (2017) · Biochimie · doi:10.1016/j.biochi.2017.05.020 · Cited by 13
Therapeutic potential of investigational CHK-1 inhibitors for the treatment of solid tumors
Babiker, H. M., McBride, A., Cooke, L. S., & Mahadevan, D. (2017) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2017.1360275 · Cited by 13
Verma, P., Kunwar, A., Arai, K., Iwaoka, M., & Priyadarsini, K. I. (2017) · Biochimie · doi:10.1016/j.biochi.2017.10.021 · Cited by 13
Claspin: From replication stress and DNA damage responses to cancer therapy
Azenha, D., Lopes, M. C., & Martins, T. (2018) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2018.10.007 · Cited by 13
Traffic safety for the cell: Influence of cyclin-dependent kinase activity on genomic stability
Enders, G. H., & Maude, S. L. (2006) · Gene · doi:10.1016/j.gene.2005.11.017 · Cited by 13
The Interaction between Two Radiosensitizers: 5-Iododeoxyuridine and Caffeine
Seo, Y., Yan, T., Schupp, J. E., Yamane, K., Radivoyevitch, T., & Kinsella, T. J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2766 · Cited by 13
Checkpoint kinase 1 negatively regulates somatic hypermutation
Frankenberger, S., Davari, K., Fischer‐Burkart, S., Böttcher, K., Tomi, N.-S., Zimber‐Strobl, U., & Jungnickel, B. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1378 · Cited by 13
Kutashev, K., Meschichi, A., Reeck, S., Fonseca, A., Sartori, K., White, C. I., Sicard, A., & Rosa, S. (2024) · New Phytologist · doi:10.1111/nph.19875 · Cited by 12
ATR function is indispensable to allow proper mammalian follicle development
Pacheco, S., Maldonado-Linares, A., Garcia-Caldés, M., & Roig, I. (2019) · Chromosoma · doi:10.1007/s00412-019-00723-7 · Cited by 12
Intrinsic ATR signaling shapes DNA end resection and suppresses toxic DNA-PKcs signaling
Dibitetto, D., Sims, J. R., Ascenção, C. F. R., Feng, K., Kim, D.-S., Oberly, S., Freire, R., & Smolka, M. B. (2020) · NAR Cancer · doi:10.1093/narcan/zcaa006 · Cited by 13
Peña-Gómez, M. J., Moreno-Gordillo, P., Narmontė, M., García-Calderón, C. B., Rukšėnaitė, A., Klimašauskas, S., & Rosado, I. V. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04952-0 · Cited by 12
Alao, J. P., Sjölander, J. J., Baar, J., Özbaki‐Yagan, N., Kakoschky, B., & Sunnerhagen, P. (2014) · Molecular Microbiology · doi:10.1111/mmi.12592 · Cited by 12
Homologous recombination defects and how they affect replication fork maintenance
Son, M. Y., & Hasty, P. (2018) · Global Medical Genetics · doi:10.3934/genet.2018.4.192 · Cited by 14
DNA Repair Pathways and Human Cancer
D’Andrea, A. D. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4066-6.00004-4 · Cited by 13
Cell Cycle–Dependent Association of Rad51 with the Nuclear Matrix
Mladenov, E., Tsaneva, I. R., & Anachkova, B. (2007) · DNA and Cell Biology · doi:10.1089/dna.2006.0503 · Cited by 12
Xiao, G., Kue, P., Bhosle, R., & Bargonetti, J. (2015) · Cell Cycle · doi:10.1080/15384101.2014.997517 · Cited by 11
Role of ataxia‐telangiectasia mutated (ATM) in porcine oocyte in vitro maturation
Lin, Z., & Kim, N. (2015) · Cell Biology International · doi:10.1002/cbin.10439 · Cited by 11
Amifostine Metabolite WR-1065 Disrupts Homologous Recombination in Mammalian Cells
Dziegielewski, J., Goetz, W., Murley, J. S., Grdina, D. J., Morgan, W. F., & Baulch, J. E. (2010) · Radiation Research · doi:10.1667/rr1982.1 · Cited by 11
Self-citationMcLachlan, J., Fernandez, S., Helleday, T., & Bryant, H. E. (2009) · DNA repair · doi:10.1016/j.dnarep.2009.09.014 · Cited by 11
Self-citationPopova, M., Henry, S., & Fleury, F. (2011) · InTech eBooks · doi:10.5772/21409 · Cited by 11
Checkpoint kinase 2 is required for efficient immunoglobulin diversification
Davari, K., Frankenberger, S., Schmidt, A., Tomi, N.-S., & Jungnickel, B. (2014) · Cell Cycle · doi:10.4161/15384101.2014.964112 · Cited by 11
Hyun, M., Choi, S., Stevnsner, T., & Ahn, B. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.12.006 · Cited by 11
DNA Damage Response/Repair in Cancer Stem Cells — Potential vs. Controversies
Louka, M. A., Boutou, E., Bakou, V., Pappa, V., Georgoulis, A., Stürzbecher, H.-W., Vorgias, C. E., & Vlachodimitropoulos, D. G. (2015) · InTech eBooks · doi:10.5772/61355 · Cited by 11
Targeting the DNA damage response in hematological malignancies
Mel, S. D., Lee, A. R. Y. B., Tan, J. H. I., Tan, R., Poon, L. M., Chan, E. H. L., Lee, J., Chee, Y. L., Lakshminarasappa, S. R., Jaynes, P. W., et al. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1307839 · Cited by 11
The evolving role of DNA damage response in overcoming therapeutic resistance in ovarian cancer
Bouberhan, S., Bar‐Peled, L., Matoba, Y., Mazina, V., Philp, L., & Rueda, B. R. (2023) · Cancer Drug Resistance · doi:10.20517/cdr.2022.146 · Cited by 10
Zhang, B., Cui, B., Du, J., Shen, X., Wang, K., Chen, J., Xiao, L., Sun, C., & Li, Y. (2019) · Cancer Management and Research · doi:10.2147/cmar.s187099 · Cited by 10
DNA damage response and repair in pancreatic cancer development and therapy
Farnood, P. R., Pazhooh, R. D., Asemi, Z., & Yousefi, B. (2021) · DNA repair · doi:10.1016/j.dnarep.2021.103116 · Cited by 11
Zhu, X., Pan, Q., Huang, N. J., Wu, J., Zhen, N., Sun, F., Li, Z., & Yang, Q. (2016) · Tumor Biology · doi:10.1007/s13277-016-5455-6 · Cited by 11
MEPE/OF45 as a new target for sensitizing human tumour cells to DNA damage inducers
Zhang, P., Wang, H., Rowe, P. S., Hu, B., & Wang, Y. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605572 · Cited by 10
Chen, G., Zhou, J., Gao, Q., Huang, X., Li, K., Zhuang, L., Huang, M. N., Xu, G., Wang, S., Lu, Y., et al. (2006) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700967 · Cited by 10
Polymerase theta is a synthetic lethal target for killing Epstein-Barr virus lymphomas
Willman, G. H., Xu, H., Zeigler, T. M., McIntosh, M. T., & Bhaduri‐McIntosh, S. (2024) · Journal of Virology · doi:10.1128/jvi.00572-24 · Cited by 9
Deng, M., Wang, P., Long, X., Xu, G., Wang, C., Li, J., Zhou, Y., & Liu, T. (2023) · ChemMedChem · doi:10.1002/cmdc.202200664 · Cited by 9
The Efficacy of CHK1 Inhibitors Is Not Altered by Hypoxia, but Is Enhanced after Reoxygenation
Hasvold, G., Nähse, V., Tkacz-Stachowska, K., Rofstad, E. K., & Syljuåsen, R. G. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0879 · Cited by 9
Self-citationRyu, J., & Koo, H. (2017) · FEBS Letters · doi:10.1002/1873-3468.12724 · Cited by 10
Cho, H. Y., Kim, Y.-B., Park, W.-H., & No, J. H. (2020) · Cancer Research and Treatment · doi:10.4143/crt.2020.1013 · Cited by 9
Xu, C., Hu, Y., Chen, B., Li, D., Liang, R., Shen, M., Wu, M., & Tao, M. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-941 · Cited by 9
Methods to Study Cancer Therapeutic Drugs That Target Cell Cycle Checkpoints
Dai, Y., & Grant, S. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-273-1_19 · Cited by 10
de Anta, J. M., Perez-Castro, A., Freire, R., & Mayol, X. (2006) · Anti-Cancer Drugs · doi:10.1097/01.cad.0000236311.73703.d2 · Cited by 9
A novel siRNA–gemcitabine construct as a potential therapeutic for treatment of pancreatic cancer
Simonenko, V., Lu, X., Roesch, E. B., Mutisya, D., Shao, C., Sun, Q., Patterson-Orazem, A. C., McNair, M., Shanmuganathan, A., Lu, P. Y., et al. (2020) · NAR Cancer · doi:10.1093/narcan/zcaa016 · Cited by 9
Drugging the DNA damage response in the clinic: going beyond PARP
Torrado, C., González-Ortiz, Á., Xavier, C. B., Tan, H. N., Ngoi, N. Y. L., & Yap, T. A. (2025) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2025.2575825 · Cited by 8
The Sm core components of small nuclear ribonucleoproteins promote homologous recombination repair
Li, Y., Kardell, M. B., Wang, F., Wang, L., Zhu, S., Bessho, T., & Peng, A. (2021) · DNA repair · doi:10.1016/j.dnarep.2021.103244 · Cited by 8
Targeting homologous recombination repair in cancer
Murfuni, I., & Rass, U. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803582-5.00008-5 · Cited by 8
Rong-Rong, L. E. I., Hu, H., Fan, B. A. I., Liu, Y., Wu, C., Huang, X., Xie, L., & Hu, Y. (2016) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(16)30062-0 · Cited by 8
Retracted: MEPE/OF45 protects cells from DNA damage induced killing via stabilizing CHK1
Liu, S., Wang, H., Wang, X., Lu, L., Gao, N., Rowe, P. S., Hu, B., & Wang, Y. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp768 · Cited by 8
RetractedSantarelli, R., Evangelista, L., Pompili, C., Presti, S. L., Rossi, A., Arena, A., Gaeta, A., Gonnella, R., Montani, M. S. G., & Cirone, M. (2023) · Virus Research · doi:10.1016/j.virusres.2023.199236 · Cited by 7
Franza, M., Albanesi, J., Mancini, B., Pennisi, R., Leone, S., Acconcia, F., Bianchi, F., & di Masi, A. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115675 · Cited by 7
Polo-Like Kinase 1 and DNA Damage Response
Li, W., & Hao, Y. (2024) · DNA and Cell Biology · doi:10.1089/dna.2024.0018 · Cited by 7
Dardare, J., Witz, A., Betz, M., François, A., Lamy, L., Husson, M., Demange, J., Rouyer, M., Lambert, A., Merlin, J., et al. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-02188-9 · Cited by 7
Jiang, S., Lin, T., Xie, Q., & Wang, L. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00383 · Cited by 7
Lage, L. A. D. P. C., Levy, D., Xavier, F. D., Reis, D. C., Costa, R. O., Gonçalves, M. D. C., Rocha, V., Zerbini, M. C. N., & Pereira, J. C. (2019) · Oncotarget · doi:10.18632/oncotarget.27098 · Cited by 7
Rajabi, F., & Mozdarani, H. (2022) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2022.104758 · Cited by 7
Song, N., Che, X., Xu, L., Qu, J., Zheng, H., Hou, K., Qu, X., & Liu, Y. (2017) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-017-3075-0 · Cited by 7
TLC388 Induces DNA Damage and G2 Phase Cell Cycle Arrest in Human Non-Small Cell Lung Cancer Cells
Wu, K.-M., Chi, C., Lai, J. C., Chen, Y.-J., & Kou, Y. R. (2020) · Cancer Control · doi:10.1177/1073274819897975 · Cited by 7
Lo, W., Chu, P., Lee, T.-H., Su, T., Chien, Y., Chen, Y., Huang, P., Tseng, L., Tu, P., Kao, S., et al. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13033277 · Cited by 7
BRCA/Fanconi anemia pathway genes in hereditary predisposition to breast cancer
Sólyom, S. (2011) · Cited by 7
Wang, Z., Jin, M., Zhai, L., Huang, B., Jin, X., Wang, X., Boudemia, A. E., Yang, X., Wei, Z., He, Y., et al. (2026) · Molecular Cell · doi:10.1016/j.molcel.2026.01.020 · Cited by 6
DNA replication-associated lesions: importance in early tumorigenesis and cancer therapy
Petermann, E., & Helleday, T. (2007) · Biochemical Society Transactions · doi:10.1042/bst0351352 · Cited by 6
Self-citationGSK3-β Stimulates Claspin Degradation via β-TrCP Ubiquitin Ligase and Alters Cancer Cell Survival
Cabrera, E., Raninga, P. V., Khanna, K. K., & Freire, R. (2019) · Cancers · doi:10.3390/cancers11081073 · Cited by 6
Li, Z., Tamari, K., Seo, Y., Minami, K., Takahashi, Y., Tatekawa, S., Otani, K., Сузукі, О., Isohashi, F., & Ogawa, K. (2020) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2020.03.047 · Cited by 6
Christy, J., Harini, Vasudevan, S., Priyadharshini, L., & Anand, D. A. (2021) · Gene Reports · doi:10.1016/j.genrep.2021.101405 · Cited by 6
Zhao, Y., Jiang, Z., Ni, T., Jiang, W., Zhou, K., Liu, Y., Li, T., & Li, T. (2021) · Genome Instability & Disease · doi:10.1007/s42764-021-00055-w · Cited by 6
A Radioprotective Effect of Imatinib (Gleevec®) in Human Squamous Carcinoma Cells
Bartkowiak, D., Hipp, P. R., Mendonca, M. S., & Röttinger, E. (2007) · Strahlentherapie und Onkologie · doi:10.1007/s00066-007-1680-7 · Cited by 6
Metadata
- Authors
- Sørensen, C. S., Hansen, L. T., Dziegielewski, J., Syljuåsen, R. G., Lundin, C., Bartek, J., & Helleday, T.
- Affiliations
- Danish Cancer Society (DK)
- University of Copenhagen (DK)
- University of Sheffield (GB)
- Stockholm University (SE)
- Corresponding author
- Helleday, Thomas
- Venue
- Nature Cell Biology
- Published
- 2005-01-23
- Volume
- 7
- Issue
- 2
- Pages
- 195-201
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- OpenAlex
- W2149795092
- Cited by
- 666
- References
- 33
- Citations by year
- 2026: 12 · 2025: 13 · 2024: 18 · 2023: 38 · 2022: 26 · 2021: 38 · 2020: 41 · 2019: 23 · 2018: 31 · 2017: 31 · 2016: 37 · 2015: 44 · 2014: 37 · 2013: 35 · 2012: 48
- FWCI
- 11.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Keywords
- Chk1, homologous recombination repair, RAD51, DNA double-strand break repair, DNA damage response, cell cycle checkpoints, hydroxyurea, camptothecin, genome maintenance, replication inhibition
- MeSH terms
- Checkpoint Kinase 1, Animals, Camptothecin, DNA, DNA Damage, DNA Repair, DNA-Binding Proteins, Cricetinae, Humans, Hydroxyurea, Protein Kinases, Recombination, Genetic, Signal Transduction, Rad51 Recombinase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review